Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29711
Full metadata record
DC FieldValueLanguage
dc.contributor.authorözen, S-
dc.contributor.authorKoné-Paut, I-
dc.contributor.authorHofer, M-
dc.contributor.authorVAN DER HILST, Jeroen-
dc.contributor.authorGül, Ahmet-
dc.contributor.authorBrogan, Paul-
dc.contributor.authorManna, Rafaelle-
dc.date.accessioned2019-10-09T13:23:47Z-
dc.date.available2019-10-09T13:23:47Z-
dc.date.issued2017-
dc.identifier.citation24th Pediatric Rheumatology Congress, Athens, Greece, 14/09/2017-
dc.identifier.urihttp://hdl.handle.net/1942/29711-
dc.language.isoen-
dc.title, Safety, Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With colchicine-resistant FMF: Results From the Phase 3 CLUSTER Trial-
dc.typeConference Material-
local.bibliographicCitation.conferencedate2017, September 14-
local.bibliographicCitation.conferencename24th Pediatric Rheumatology Congress-
local.bibliographicCitation.conferenceplaceAthens, Greece-
local.bibliographicCitation.jcatC2-
local.type.refereedRefereed-
local.type.specifiedConference Poster-
dc.identifier.doi10.1186/s12969-017-0186-9-
item.fulltextWith Fulltext-
item.contributorözen, S-
item.contributorKoné-Paut, I-
item.contributorHofer, M-
item.contributorVAN DER HILST, Jeroen-
item.contributorGül, Ahmet-
item.contributorBrogan, Paul-
item.contributorManna, Rafaelle-
item.fullcitationözen, S; Koné-Paut, I; Hofer, M; VAN DER HILST, Jeroen; Gül, Ahmet; Brogan, Paul & Manna, Rafaelle (2017) , Safety, Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With colchicine-resistant FMF: Results From the Phase 3 CLUSTER Trial. In: 24th Pediatric Rheumatology Congress, Athens, Greece, 14/09/2017.-
item.accessRightsOpen Access-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
published abstract canakinumab pediatric rheumatology.pdfConference material1.55 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.